Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • spapillon
    Junior Member
    • Nov 2011
    • 4

    Problems with RNA-seq analysis results

    Hi everyone,

    This is my first post here, be sure to let me know if I break a rule of conduct or anything. Tricks & Tips are appreciated.

    The situation:
    I'm currently trying to analyze RNA-seq data from Illumina Body Map 2.0. I've built a pipeline that seems reasonable and used it to asses quality, trim, map, analyze RNA-seq data with the standard tools. The pipeline is for 100bp single end reads.

    The pipeline:
    Quality (fastx_tools for trimming and filtering, FastQC for reporting)
    fastq_quality_filter -Q33 -q 20 -p 80 <FASTQC_FILE>
    fastq_quality_trimmer -Q33 -t 20 -l 50 <FILTER_OUT>
    fastqc <TRIM_OUT>

    Assembling
    tophat --solexa-quals <UCSC hg19 REF> <TRIM_OUT>

    Analysis
    cufflinks <TOPHAT_OUT>
    cuffcompare -r <UCSC hg19 ANNOTATION> -R <CUFFLINKS_OUT>

    The problems
    The output of cuffcompare (cuffcmp.tacking) identifies:
    13586 [23.32%] novel (class code j)
    6127 [10.51%] intronic (class code i)
    19145 [32.86%] contained (class code c)

    In this sample, novel+intronic > contained. I'm highly dubious of the trustfulness of those results since one would not expect such high number of non previously reported transcripts. If anyone could point out a flaw in the pipeline or my interpretation of the obtained results I would greatly appreciate it. Do tell if I need to give more details on any part.

    Best regards,

    Simon
    Last edited by spapillon; 11-29-2011, 09:48 PM.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...